Get all your news in one place.

100’s of premium titles.
One app.

Get all your news in one place.

100’s of premium titles. One news app.

The Latest Breaking News from Johnson & Johnson

AstraZeneca vs. Johnson & Johnson: Which Drug Manufacturer is a Better Buy?

The COVID-19 pandemic has boosted the revenues of most drug manufacturers. And since healthcare expenditure has been climbing steadily, and because the global population is aging, the demand for medicines is expected to grow. Quality drug manufacturers AstraZeneca (AZN) and Johnson & Johnson (JNJ) should benefit from this trend. But…

StockNews.com

This Day In Market History: Walmart, Johnson & Johnson Join Dow Jones Industrial Average

Each day, Benzinga takes a look back at a notable market-related moment that occurred on this date.

Benzinga

Where Johnson & Johnson Stands With Analysts

Over the past 3 months, 4 analysts have published their opinion on Johnson & Johnson (NYSE:JNJ) stock. These analysts are typically employed by large Wall Street banks and tasked with understanding a company's business to predict how a stock will trade over the upcoming year.

Benzinga

From analysis to the latest developments in health,
read the most diverse news in one place.

Expert Ratings For Johnson & Johnson

Johnson & Johnson (NYSE:JNJ) has observed the following analyst ratings within the last quarter:

Benzinga

What Are Whales Doing With Johnson & Johnson

A whale with a lot of money to spend has taken a noticeably bullish stance on Johnson & Johnson. Looking at options history for Johnson & Johnson (NYSE:JNJ) we detected 21 strange trades.

Benzinga

JNJ Regrets Paying For Controversial Prison Testing With Asbestos: Bloomberg

According to a Bloomberg News report, unsealed court documents show that Johnson & Johnson (NYSE:

Benzinga

This Is What Whales Are Betting On Johnson & Johnson

A whale with a lot of money to spend has taken a noticeably bearish stance on Johnson & Johnson. Looking at options history for Johnson & Johnson (NYSE:JNJ) we detected 28 strange trades.

Benzinga

Read news from The Economist, FT, and more,
with one subscription

Benzinga Bulls And Bears Of The Past Week: Shopify, Palantir, Apple, Meta, Twitter, Johnson & Johnson, American Express And More

Benzinga has examined the prospects for many investor favorite stocks over the past week.

Benzinga

To be 1 in a million: ‘Who thinks it’s going to be you?’

BEND, Ore. — Monica Melkonian wanted the Johnson & Johnson COVID-19 vaccine. It was only one shot and then she would be protected against the virus. So she was thrilled when the vaccination clinic at the Deschutes County Fair & Expo Center on April 7 had her first choice.

Tribune News Service

Johnson & Johnson's COVID-19 Vaccine Less Effective Against Hospitalization, French Study Shows

According to a large French study, the risk of hospitalization after vaccination with Johnson & Johnson's (NYSE: JNJ) COVID-19 vaccine was about five times higher than those who received the Pfizer Inc (NYSE:

Benzinga

This Is What Whales Are Betting On Johnson & Johnson

Someone with a lot of money to spend has taken a bearish stance on Johnson & Johnson (NYSE:JNJ). And retail traders should know. We noticed this today when the big position showed up on publicly available options history that we track here at Benzinga.

Benzinga

Johnson & Johnson Allowed To Move Ahead With Bankruptcy Strategy On Talc Lawsuits: WSJ

In a federal bankruptcy court in Trenton, New Jersey, Judge Michael Kaplan ruled in favor of Johnson & Johnson's (NYSE: JNJ) controversial bankruptcy filing meant to settle 38,000 claims alleging its talc-based products caused cancer.

Benzinga

Johnson & Johnson Sees A Strong Move: Is It Ready For A Breakout?

Johnson & Johnson (NYSE: JNJ) shares are trading higher Friday after the company agreed to finalize a proposed $26 billion settlement resolving more than 3,000 lawsuits, mainly by state and local governments, seeking to hold it and three other companies responsible for th

Benzinga

Does CBD Have To Be Water Soluble? One Group Of Scientists Say Yes For Better Absorption

Several former scientists and staff from companies like Johnson & Johnson (NYSE: JNJ), GlaxoSmithKline (NYSE: GSK) and Schiff Nutrition are bringing a new delivery platform to market that boosts the bioavailability of&

Benzinga

Get all your
news in one place.

100’s of premium titles.
One news app.

Chicago Sun-Times

Illinois gets $760M as part of opioid settlement with Johnson & Johnson, 3 drug distribution companies

The money will be distributed to local governments around the state to help battle the opioid crisis

The Independent UK

J&J, distributors finalize $26B landmark opioid settlement

Drugmaker Johnson & Johnson and three major distributors have finalized a nationwide settlement over their role in the opioid addiction crisis

Benzinga

Johnson & Johnson Whale Trades For February 24

A whale with a lot of money to spend has taken a noticeably bearish stance on Johnson & Johnson. Looking at options history for Johnson & Johnson (NYSE:JNJ) we detected 17 strange trades.

Benzinga

Johnson & Johnson Whale Trades Spotted

A whale with a lot of money to spend has taken a noticeably bearish stance on Johnson & Johnson. Looking at options history for Johnson & Johnson (NYSE:JNJ) we detected 20 strange trades.

Get all your
news in one place.

100’s of premium titles.
One news app.

Benzinga

Janssen's Tremfya Shows Clinical Response At 12 Weeks In Ulcerative Colitis

Janssen Pharmaceutical, a unit of Johnson & Johnson (NYSE: JNJ), has announced results from the

Benzinga

AC Immune-Janssen Partnered Alzheimer's Vaccine Shows Tau-Specific Antibodies In Early-Stage Trial

AC Immune SA (NASDAQ: ACIU) and partner Janssen, a unit of Johnson & Johnson (NYSE: JNJ), have found that an early-stage Alzheimer's vaccine spurs induction of antibodies that attack a type of tau, a

Benzinga

Why Are AstraZeneca Shares Trading Higher Today

Adding AstraZeneca Plc's (NASDAQ: AZN) Lynparza to Johnson & Johnson's (NYSE: JNJ) Zytiga (abiraterone) extended the time to live without disease progression in patients with newly diagnosed

Tribune News Service

J&J starts trial on bankruptcy case under attack by Congress

The controversial Johnson & Johnson bankruptcy strategy that’s drawn the ire of Congress faces a fresh trial this week, with the consumer products giant arguing that settling billions of dollars of talc liabilities in a single case is better for cancer victims than fighting thousands of individual claims.

Benzinga

Benzinga Bulls And Bears Of The Past Week: Meta, Spotify, Peloton, Twitter, Johnson & Johnson And More

Benzinga has examined the prospects for many investor favorite stocks over the past week.

Asharq Al-Awsat

US Ships Nearly 1.9 Mn More COVID Vaccine Doses to African Nations

The United States on Friday shipped nearly 1.9 million COVID-19 vaccine doses to Mozambique and four other African countries in the latest surge of donations, a US official told AFP. "Thanks to the US commitment to playing a leading role in ending the pandemic everywhere," Mozambique will receive 840,000 Johnson…

Benzinga

Final Analysis Show Johnson & Johnson's COVID-19 Offers Only 52.9% Protection

Scientists have revealed data from their final analysis of Johnson & Johnson's (NYSE: JNJ) COVID-19 Phase 3 study, showing the vaccine may be even less effective in the longer term.

1 2

People

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

Read news from The Economist, FT, and more,
with one subscription

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.